Multifunctional Graphene Oxide Nanodelivery Platform for Breast Cancer Treatment

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2022 Dec 22

PMID 36545221

Authors

Yousheng Mo

Wei Liu

Piaoxue Liu

Qiao Liu

Zhongyu Yuan

Qi Wang

Dongsheng Yuan

Xiao-Jia Chen

Tongkai Chen

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer (BC) has the highest global prevalence among all malignancies in women and the second highest prevalence in the overall population. Paclitaxel (PTX), a tricyclic diterpenoid, is effective against BC. However, its poor solubility in water and the allergenicity of its dissolution medium limited its clinical application.

Methods: In this work, we established a multifunctional graphene oxide (GO) tumor-targeting drug delivery system using nanosized graphene oxide (nGO) modified with D-tocopherol polyethylene glycol succinate (TPGS) and arginine-glycine-aspartic acid (RGD) for PTX loading.

Results: The obtained RGD-TPGS-nGO-PTX was 310.20±19.86 nm in size; the polydispersity index (PDI) and zeta potential were 0.21±0.020 and -23.42 mV, respectively. The mean drug loading capacity of RGD-TPGS-nGO-PTX was 48.78%. RGD-TPGS-nGO-PTX showed satisfactory biocompatibility and biosafety and had no significant toxic effects on zebrafish embryos. Importantly, it exerted excellent cytotoxicity against MDA-MB-231 cells, reversed multi-drug resistance (MDR) in MCF-7/ADR cells, and showed significant anti-tumor efficacy in tumor-bearing nude mice.

Conclusion: These findings strongly suggested that the multifunctional GO tumor-targeting drug delivery system RGD-TPGS-nGO-PTX could be used in clinical settings to improve PTX delivery, reverse MDR and increase the therapeutic efficacy of BC treatment.

References

Shimomura A, Yonemori K, Yoshida M, Yoshida T, Yasojima H, Masuda N . Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy. Transl Oncol. 2019; 12(10):1386-1394. PMC: 6698310. DOI: 10.1016/j.tranon.2019.07.013. View

Curigliano G, Pravettoni G . Use of chemotherapy in elderly patients with early-stage triple-negative breast cancer. Lancet Oncol. 2020; 21(12):1543-1545. DOI: 10.1016/S1470-2045(20)30694-X. View

Lee K, Nallathamby P, Browning L, Osgood C, Xu X . In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. ACS Nano. 2009; 1(2):133-43. PMC: 2613370. DOI: 10.1021/nn700048y. View

Zavareh H, Pourmadadi M, Moradi A, Yazdian F, Omidi M . Chitosan/carbon quantum dot/aptamer complex as a potential anticancer drug delivery system towards the release of 5-fluorouracil. Int J Biol Macromol. 2020; 165(Pt A):1422-1430. DOI: 10.1016/j.ijbiomac.2020.09.166. View

Xiao W, Wang Y, Lau E, Luo J, Yao N, Shi C . The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle. Mol Cancer Ther. 2010; 9(10):2714-23. PMC: 3571112. DOI: 10.1158/1535-7163.MCT-10-0308. View

Lee H, Park S, Kang J, Lee H, Kim S, Rhie S . Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis. Sci Rep. 2020; 10(1):530. PMC: 6969039. DOI: 10.1038/s41598-019-57380-0. View

Orecchioni M, Cabizza R, Bianco A, Delogu L . Graphene as cancer theranostic tool: progress and future challenges. Theranostics. 2015; 5(7):710-23. PMC: 4402495. DOI: 10.7150/thno.11387. View

Varela-Lopez A, Vera-Ramirez L, Giampieri F, Navarro-Hortal M, Forbes-Hernandez T, Battino M . The central role of mitochondria in the relationship between dietary lipids and cancer progression. Semin Cancer Biol. 2021; 73:86-100. DOI: 10.1016/j.semcancer.2021.01.001. View

Azizi M, Ghourchian H, Yazdian F, Dashtestani F, Alizadehzeinabad H . Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231. PLoS One. 2017; 12(11):e0188639. PMC: 5706725. DOI: 10.1371/journal.pone.0188639. View

10.

Li Y, Li R, Liu Q, Li W, Zhang T, Zou M . One-Step Self-Assembling Nanomicelles for Pirarubicin Delivery To Overcome Multidrug Resistance in Breast Cancer. Mol Pharm. 2016; 13(11):3934-3944. DOI: 10.1021/acs.molpharmaceut.6b00712. View

11.

van Vliet E, Iyer A, Mesarosova L, Colakoglu H, Anink J, van Tellingen O . Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients. J Neuropathol Exp Neurol. 2020; 79(3):266-276. PMC: 7036662. DOI: 10.1093/jnen/nlz142. View

12.

Dan V, Raveendran R, Baby S . Resistance to Intervention: Paclitaxel in Breast Cancer. Mini Rev Med Chem. 2020; 21(10):1237-1268. DOI: 10.2174/1389557520999201214234421. View

13.

Fu S, Zhao Y, Sun J, Yang T, Zhi D, Zhang E . Integrin αβ-targeted liposomal drug delivery system for enhanced lung cancer therapy. Colloids Surf B Biointerfaces. 2021; 201:111623. DOI: 10.1016/j.colsurfb.2021.111623. View

14.

Wu M, Huang T, Wang J, Chen P, Mi W, Ying Y . Antilung cancer effect of ergosterol and cisplatin-loaded liposomes modified with cyclic arginine-glycine-aspartic acid and octa-arginine peptides. Medicine (Baltimore). 2018; 97(33):e11916. PMC: 6113040. DOI: 10.1097/MD.0000000000011916. View

15.

Ryu B, Kim C, Oh H, Kim U, Kim J, Jung C . Development of an alternative zebrafish model for drug-induced intestinal toxicity. J Appl Toxicol. 2017; 38(2):259-273. DOI: 10.1002/jat.3520. View

16.

Huang Q, Kuok K, Zhang X, Yue L, Lee S, Zhang J . Inhibition of drug-induced seizure development in both zebrafish and mouse models by a synthetic nanoreceptor. Nanoscale. 2018; 10(22):10333-10336. DOI: 10.1039/c8nr02041h. View

17.

de Melo-Diogo D, Pais-Silva C, Costa E, Louro R, Correia I . D-α-tocopheryl polyethylene glycol 1000 succinate functionalized nanographene oxide for cancer therapy. Nanomedicine (Lond). 2017; 12(5):443-456. DOI: 10.2217/nnm-2016-0384. View

18.

Cardenas C, Lovy A, Silva-Pavez E, Urra F, Mizzoni C, Ahumada-Castro U . Cancer cells with defective oxidative phosphorylation require endoplasmic reticulum-to-mitochondria Ca transfer for survival. Sci Signal. 2020; 13(640). PMC: 9387586. DOI: 10.1126/scisignal.aay1212. View

19.

Abdelhamid H, El-Bery H, Metwally A, Elshazly M, Hathout R . Synthesis of CdS-modified chitosan quantum dots for the drug delivery of Sesamol. Carbohydr Polym. 2019; 214:90-99. DOI: 10.1016/j.carbpol.2019.03.024. View

20.

Chen Y, Feng S, Liu W, Yuan Z, Yin P, Gao F . Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy. Mol Pharm. 2017; 14(4):1190-1203. DOI: 10.1021/acs.molpharmaceut.6b01068. View